ABBOTT LABORATORIES (ABT) Operating income 2016–2025
ABBOTT LABORATORIES (ABT) annual operating income history from SEC filings — each fiscal year as reported.
$8.1BFY2025 · since FY2016: $3.0B → $8.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1B | +18.0% |
| FY2024 | $6.8B | +5.4% |
| FY2023 | $6.5B | -22.5% |
| FY2022 | $8.4B | -0.7% |
| FY2021 | $8.4B | +57.3% |
| FY2020 | $5.4B | +18.2% |
| FY2019 | $4.5B | +24.2% |
| FY2018 | $3.6B | +133.4% |
| FY2017 | $1.6B | -48.3% |
| FY2016 | $3.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice